These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11948283)

  • 1. Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.
    Restivo DA; Palmeri A; Marchese-Ragona R
    N Engl J Med; 2002 Apr; 346(15):1174-5. PubMed ID: 11948283
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A.
    Albanese A; Brisinda G; Bentivoglio AR; Maria G
    Am J Gastroenterol; 2003 Jun; 98(6):1439-40. PubMed ID: 12818293
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N; Honigman S
    Mov Disord; 1997 Nov; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of globus by upper esophageal sphincter injection with botulinum A toxin.
    Halum SL; Butler SG; Koufman JA; Postma GN
    Ear Nose Throat J; 2005 Feb; 84(2):74. PubMed ID: 15794538
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum.
    Spinelli P; Ballardini G
    Surg Endosc; 2003 Apr; 17(4):660. PubMed ID: 12574934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
    J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A; Rodrigues B; Nóbrega AC
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract]   [Full Text] [Related]  

  • 12. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous chemical myotomy using botulium neurtoxin A under local anaesthesia in the treatment of cricopharyngeal dysphagia following laryngectomy.
    Natt RS; McCormick MS; Clayton JM; Ryall C
    Auris Nasus Larynx; 2010 Aug; 37(4):500-3. PubMed ID: 20036474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
    Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
    BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease.
    Kulaksizoglu H; Parman Y
    Parkinsonism Relat Disord; 2010 Sep; 16(8):531-4. PubMed ID: 20637678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pharyngoesophageal spasm with Botox.
    Chao SS; Graham SM; Hoffman HT
    Otolaryngol Clin North Am; 2004 Jun; 37(3):559-66. PubMed ID: 15163601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction.
    Kim DY; Park CI; Ohn SH; Moon JY; Chang WH; Park SW
    Arch Phys Med Rehabil; 2006 Oct; 87(10):1346-51. PubMed ID: 17023244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin A: an unusual systemic effect.
    Howell K; Selber P; Graham HK; Reddihough D
    J Paediatr Child Health; 2007 Jun; 43(6):499-501. PubMed ID: 17535186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cricopharyngeal Botox injection: indications and technique.
    Moerman MB
    Curr Opin Otolaryngol Head Neck Surg; 2006 Dec; 14(6):431-6. PubMed ID: 17099352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin as a preventive treatment for migraine and chronic tension headache.
    Cattin T
    N Z Med J; 2003 May; 116(1174):U440. PubMed ID: 12766786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.